LMB-2 Immunotoxin and Vaccine Therapy in Treating Patients With Metastatic Melanoma That Cannot Be Removed By Surgery

NCT00295958 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

26

Enrollment

NIH

Sponsor class

Conditions

Melanoma (Skin)
Non-melanomatous Skin Cancer

Interventions

BIOLOGICAL: LMB-2 immunotoxin
BIOLOGICAL: MART-1 antigen
BIOLOGICAL: gp100 antigen
BIOLOGICAL: incomplete Freund's adjuvant

Sponsor

National Institutes of Health Clinical Center (CC)

Collaborators

[object Object]